FOCUS UNIVERSAL INC. (FCUV): Nasdaq/NYSE listing notice — Focus Universal receives Nasdaq delisting notice for MVLS below $35M

FOCUS UNIVERSAL INC.

Received Nasdaq notice on June 30, 2025 for violating Listing Rule 5550(b)(2) (MVLS below $35 million).
Has 180 days, until December 29, 2025, to regain compliance with MVLS >= $35M for 10 consecutive business days.
If compliance not regained by deadline, Nasdaq will issue delisting notification; company evaluating options.
No immediate effect on listing; common stock continues trading on Nasdaq Capital Market during compliance period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

FOCUS UNIVERSAL INC. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5550(b)(2), 5810(c)(3)(C)

Exact text from the filing

June 30, 2025, Focus Universal Inc. (the “Company”), received a letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”). The Staff notified the Company that since the Company’s Market Value of Listed Securities has fallen below $35,000,000, the Company no longer satisfies the requirements under Nasdaq Listing Rule 5550(b)(2) (the “MVLS Rule”). The notification received has no immediate effect on the Company’s Nasdaq listing. In accordance with Nasdaq Listing Rule 5810(c)(3)(C) (the “Compliance Period Rule”), the Company has been provided an initial

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

FOCUS UNIVERSAL INC. filing history →

Source: SEC EDGAR

accession 0001683168-25-004919

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.